Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

(x) Reserves

Share
premium
account
£'000
Hedging
reserve
£'000
Profit
and loss
account
£'000
At 1 July 201163,559(294)8,453
New shares issued59,083
Profit for the financial year4,293
Effective portion of changes in fair value of cash flow hedges(335)
Cash flow hedges recycled to profit and loss account343
Dividend (see note 9 to the consolidated financial statements)(8,325)
Share-based payments charge1,001
At 30 June 2012122,642(286)5,422

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.